0

symptoms of type 2 diabetes

Báo cáo y học:

Báo cáo y học: "A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes"

Y học thưởng thức

... Manifestations of chronic disease during pregnancy Jama 20 05, 29 4 :27 51 -27 57 49 Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type diabetes: a systematic review Diabetes Care 20 02, 25 :18 62- 1868 ... (43.6%) 20 2 (56.4%) P < 0.001 ACSb Diagnoses (N, %) 322 97 (30.1%) 22 5 (69.9%) - other diagnoses 331 99 (29 .9%) 23 2 (70.1%) Age (years) 58 (19 to 87) 59 (22 to 87) 58 (19 to 86) P = 0 .21 4 Male ... diagnosing diabetes mellitus J Clin Endocrinol Metab 20 08, 93 :24 47 -24 53 46 International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 20 09, 32: 1 327 -1334...
  • 8
  • 656
  • 1
 Báo cáo y học:

Báo cáo y học: "The association of meat intake and the risk of type 2 diabetes may be modified by body weight"

Y học thưởng thức

... 1659.4 2. 8 2. 2 2. 2 2. 68 38.6 30.9 36.0 33.8 38.8 34.3 33.1 32. 3 23 .7 10.8 11.53 42. 3 30.6 15.5 36.1 34.3 21 .1 8.5 9.9 38.9 33.8 17.3 32. 7 31.8 22 .8 12. 6 18.4 38.3 29 .3 14.1 20 .2 38.8 24 .7 16.3 ... 29 .7 17.9 22 .1 41.4 23 .7 12. 8 12. 3 35.9 30.7 21 .0 23 .8 39.4 24 .1 12. 7 14.7 37.9 28 .9 18.4 14.6 9.6 15.3 60.5 9.7 0.4 2. 3 28 .6 20 .9 14.7 26 .3 38.0 4.4 0.1 1.4 16.8 11.7 9.8 17.5 61.0 8.3 0.3 2. 7 ... 2. 7 26 .2 23.6 14.0 24 .4 38.0 5.6 0.1 1.4 18.9 14.5 9.7 15.6 60 .2 9.1 0 .2 3.6 26 .1 19.8 12. 6 22 .3 45.3 6.4 0.7 1.6 21 .6 Int J Med Sci 20 06, 158 Table 2: Unprocessed meat intake and risk of type diabetes...
  • 8
  • 701
  • 0
TOPICS IN THE PREVENTION, TREATMENT AND COMPLICATIONS OF TYPE 2 DIABETES pptx

TOPICS IN THE PREVENTION, TREATMENT AND COMPLICATIONS OF TYPE 2 DIABETES pptx

Sức khỏe giới tính

... Mathieu, C (20 05) Prediabetes essential action: a European perspective, Diabetes & Metabolism, Vol 31, No 6, 20 05, pp 606- 620 , ISSN 126 2-3636, doi : DM- 12- 2005-31-6- 126 2-3636-10101 920 05163 42 WHO - ... 10 20 30 40 50 60 age [years] 70 80 90 100 Fig 15 Number of people in Slovenia from 20 03 to 20 52 6000 5000 20 52 number 4000 20 03 3000 20 00 1000 0 10 20 30 40 50 age [yeas] Fig 16 Number of D2 ... majority of working people, is diminished Combination of modelling results from Fig 15 and the prevalence of D2 model is shown in Fig 16 3.5 x 10 number of people from 20 03 to 20 52 2003 2. 5 1.5 20 52...
  • 352
  • 478
  • 0
ROLE OF THE ADIPOCYTE IN DEVELOPMENT OF TYPE 2 DIABETES potx

ROLE OF THE ADIPOCYTE IN DEVELOPMENT OF TYPE 2 DIABETES potx

Sức khỏe giới tính

... associated with incident of metabolic syndrome A prospective study of men and women Circulation Vol 1 12, No (July 20 05), pp 505- 12 22 Role of the Adipocyte in Development of Type Diabetes Lee SJ, Kuk ... metformin 16 Role of the Adipocyte in Development of Type Diabetes effects (Tang et al., 20 01), acting as co-adjuvants in the reduction of the incident of diabetes (Doggrell, 20 02) , increasing vascular ... Asp, 20 05; Olofsson et al., 1999; Olofsson et al., 20 00; Stillemark-Billton et al., 20 05) 2. 1 .2 VLDL2 VLDL2 formation is highly dependent on the length of apoB, and truncated forms of apoB result...
  • 382
  • 1,251
  • 0
MEDICAL COMPLICATIONS OF TYPE 2 DIABETES potx

MEDICAL COMPLICATIONS OF TYPE 2 DIABETES potx

Sức khỏe giới tính

... predicts future risk of type diabetes Diabetes/Metabolism Research and Reviews, Vol .26 , No.4, (May 20 10), pp 28 0 -28 6, ISSN: 1 520 -75 52 American Diabetes Association (1997) Report of the Expert Committee ... Borch-Johnsen, K (20 09) Development of a type diabetes risk model from a panel of serum biomarkers from the Inter99 cohort Diabetes Care, Vol. 32, No.7, (July 20 09), pp 120 7- 121 2, ISSN: 0149-59 92 Kramer ... Classification of Diabetes Mellitus Diabetes Care, Vol 20 , No.7, (July 1997), pp 1183-1197, ISSN: 0149-59 92 American Diabetes Association (20 08) Economics costs of diabetes in the U.S in 20 07 Diabetes...
  • 422
  • 424
  • 0
RECENT ADVANCES IN THE PATHOGENESIS, PREVENTION AND MANAGEMENT OF TYPE 2 DIABETES AND ITS pptx

RECENT ADVANCES IN THE PATHOGENESIS, PREVENTION AND MANAGEMENT OF TYPE 2 DIABETES AND ITS pptx

Sức khỏe giới tính

... the mean intensity of the image t* = and arg 1≦t<L 2 max{σB (t)|σB = w1(μ1 –μT )2 + w2( 2 –μT )2} (6) 22 Recent Advances in the Pathogenesis, Prevention and Management of Type Diabetes and its Complications ... DH (20 01) A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia Stroke, Vol 32, No 9, pp 20 93 -20 98,1 524 4 628 (Electronic) Wall PD (1977) The presence of ... Complications in Diabetic Patients 337 Kyuzi Kamoi Aspects of the Treatment of Type Diabetes 373 Chapter 20 Emerging Challenge of Type Diabetes: Prospects of Medicinal Plants 375 Rokeya Begum, Mosihuzzaman...
  • 454
  • 407
  • 0
Báo cáo y học:

Báo cáo y học: "Association of Adiposity, Cardiorespiratory Fitness and Exercise Practice with the Prevalence of Type 2 Diabetes in Brazilian Elderly Women" pot

Báo cáo khoa học

... 22 .3 1.0 1.69 (1. 02- 2. 82) 2. 83 (1.71-4.69) 1.0 1.59 (0.95 -2. 66) 2. 55 (1. 52- 4 .28 ) 1.0 1. 52 (0.90 -2. 55) 2. 28 (1.35-3.85) WC (cm) ≤ 80 80.1-86.9 87.0-93.9 ≥ 94.0 6.6 14.1 19.0 24 .7 1.0 2. 31 (1 .29 -4. 12) ... 18 19 20 21 22 23 24 25 26 27 28 Adiposity and Diabetes in Older Adults Diabetes Care 20 04; 27 : 1375-1380 Bloomgarden ZT Adiposity and Diabetes Diabetes Care 20 02; 25 : 23 42- 2349 Kahn BB, Flier ... (95%CI) 10.4 12. 0 19.6 21 .0 1.0 1.18 (0.67 -2. 07) 2. 11 (1 .26 -3.53) 2. 30 (1.37-3.84) 1.0 1.18 (0.75-1.85) 1.0 1.17 (0.66 -2. 05) 1.98 (1.18-3.34) 2. 19 (1.30-3.58) 1.0 1 .22 (0.77-1. 92) 1.0 1. 12 (0.63-1.99)...
  • 5
  • 426
  • 0
Báo cáo y học:

Báo cáo y học: " Barriers and facilitators to evidence based care of type 2 diabetes patients: experiences of general practitioners participating to a quality improvement program" ppt

Báo cáo khoa học

... patients with type diabetes N Engl J Med 20 03, 348:383-393 Colagiuri S, Best J: Lipid-lowering therapy in people with type diabetes Curr Opin Lipidol 20 02, 13:617- 623 23 24 25 26 27 28 29 30 Gaede ... 11 12 13 14 15 16 17 18 19 20 21 22 References The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of ... intensive glucose control in type diabetes N Engl J Med 20 08, 359:1577-1589 American Diabetes Association: Standards of medical care in diabetes – 20 07 Diabetes Care 20 07, 30(Suppl 1):S4-S41 Bowman...
  • 11
  • 400
  • 0
báo cáo khoa học:

báo cáo khoa học:" Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China" docx

Báo cáo khoa học

... 434 161 (37.1) 39 (9.0) 122 (28 .1) 53 ( 12. 2) 95 (21 .9) (1.4) 28 9 (66.6) χ2trend = 32. 30 χ2trend = 11.09 χ2trend = 65.49 χ2trend = 3.95 χ2trend = 25 . 62 χ2trend = 4.54 χ2trend = 91.90 p < 0.001 ... 1996, 21 (9) :27 0 -27 2 26 Tang L, Chen X, Chen H, Zhao L, Hu S: The financing burden of treatment of diabetesII and Its symptom in urban China Chinese Health Economics 20 03, 22 ( 12) :21 -23 27 Prevalence ... 199 (49.8) 2 = 29 . 62 2 = 8.44 2 = 7 .29 2 = 1.11 2 = 6.88 2 = 1.71 2 = 8.76 p < 0.001 Liu et al Health and Quality of Life Outcomes 20 10, 8: 62 http://www.hqlo.com/content/8/1/ 62 Beijing p...
  • 9
  • 330
  • 0
management of type 2 diabetes focus on insulin therapy

management of type 2 diabetes focus on insulin therapy

Nội khoa

... Injection in Type Diabetes 350 300 Lispro insulin 25 0 Aspart insulin 20 0 150 100 50 Time (Hours) 11 Hedman C et al Diabetes Care 20 01 ;24 :1 120 -1 121 (abstract #465) International Diabetes Center ... injection of RA for snacks RA RA RA Glargine 50 40 30 20 RA SMBG RA SMBGRA 10 SMBG SMBG Glargine 0 10 12 14 16 18 20 22 24 Hours International Diabetes Center Starting Insulin at Diagnosis of Diabetes ... insulin secretion 50 Glargine (0.1 U/kg) Glimepiride ( mg) 40 30 20 Glargine 10 0 10 12 14 16 18 20 22 24 Time of Day International Diabetes Center Metformin + Insulin Sensitizer Liver • Gluconeogenesis...
  • 45
  • 507
  • 0
mechanisms of type 2 diabetes

mechanisms of type 2 diabetes

Nội khoa

... with type diabetes and over 60% of patients with type diabetes have retinopathy Proportion of patients with cardiovascular disease increases with duration of type diabetes 48% 29 % 21 % 24 % 15% < =2 ... duration of type diabetes 67% 62% 53% 42% 31% < =2 3-5 6-9 10-14 15+ Years T2DM Harris,S et al CDA 20 03; Type Diabetes and Associated Complications in Primary Care in Canada: The Impact of Duration of ... common cause of new cases of blindness among adults 20 -74 years of age • Each year, between 12, 000 to 24 ,000 people lose their sight because of diabetes • During the first two decades of disease,...
  • 31
  • 495
  • 0
Báo cáo y học:

Báo cáo y học: " Ranking candidate genes in rat models of type 2 diabetes" pptx

Báo cáo khoa học

... Modelling 20 09, 6: 12 ing type diabetes [27 ] Due to its multiple functions, the glucose regulating function of RXRA is only briefly mentioned in OMIM resulting in a CGC point of 32. 3 SLC2A8 is another ... Indian J Med Res 20 07, 125 :451-4 72 Portha B: Programmed disorders of beta-cell development and function as one cause for type diabetes? The GK rat paradigm Diabetes Metab Res Rev 20 05, 21 :495-504 Cox ... 1994, 196:197 -21 2 Phay JE, Hussain HB, Moley JF: Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9) Genomics 20 00, 66 :21 7 -22 0 Ollmann...
  • 9
  • 345
  • 0
Báo cáo y học:

Báo cáo y học: "Correction: A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes" pdf

Báo cáo khoa học

... Care 20 10, 14:444 http://ccforum.com/content/14/5/444 Page of 22 07 patients admitted to medical ICU 385 with a history of DM, IFG or IGT 1 822 27 4 died in hospital 1548 screened 443 excluded - 21 1 ... participation - 20 3 terminally ill - 29 receiving corticosteroids 669 436 NORMOGLYCAEMIA HYPERGLYCAEMIA 76 excluded: - newly diagnosed DM, IGT or IFG 669 360 started follow-up 1 02 died 154 discontinued ... 14 DM 326 normoglycaemic finished follow-up 66 died 93 discontinued follow-up started steroid treatment 193 47 IGF / IFG 33 DM 113 normoglycaemic Figure Flow diagram showing the loss of patients...
  • 2
  • 259
  • 0
METFORMIN – MORE THAN ‘GOLD STANDARD’ IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

METFORMIN – MORE THAN ‘GOLD STANDARD’ IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Y học thưởng thức

... adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 20 09; 32: 193 -20 3 Sterne J Treatment of diabetes ... with type diabetes mellitus Diabetes Med 20 05 ;22 : 128 2- 128 4 34 Jung HS, Youn BS, Cho YM, Yu KY, Park HJ, Shin CS, et al The effects of rosiglitazone and metformin on the plasma concentrations of ... type diabetes Diabetes Care 20 03 ;26 :23 70 -23 77 27 Lindsay JR, Duffy NA, McKillop AM, Ardill J, O'Harte FP, Flatt PR, et al Inhibition of dipeptidyl peptidase IV activity by oral metformin in type...
  • 10
  • 420
  • 0
The genetic basis of type 2 diabetes in a multi ethnic population in singapore

The genetic basis of type 2 diabetes in a multi ethnic population in singapore

Cao đẳng - Đại học

... 0.001 Risk of T2DM [OR (95%CI)] 1.61 (1.10 -2. 33) 1.60 (1.09 -2. 32) 1.59 (1.09 -2. 32) 1.57 (1.08 -2. 25) 1. 52 (1.04 -2. 21) 1.63 (1.11 -2. 38) 1.53 (1.04 -2. 24) 1.60 (1.09 -2. 32) 1.57 (1.08 -2. 29) p-value*/p-value† ... rs9939973 523 58069 0.5 72 0. 826 0. 128 0.8 82 0.18 0.31 0.43 0.33 97.9 99.7 rs9940 128 523 5 825 5 0. 527 0.785 0. 121 0.8 82 0.18 0. 32 0.43 0.33 98.1 99.5 rs1 421 085 523 58455 0.653 0.303 0 .27 0.9 62 0. 12 0 .28 0.35 ... 1-1-1-1-1-1-1-1-1; Haplotype 2: 2- 2-1 -2- 1-1-1-1-1; Haplotype 3 :2- 2 -2- 2 -2- 2 -2- 2 -2- 2 (where 1=common allele, 2= minor allele) *Adjusted for age and sex † Adjusted for age, sex, BMI Table 13 Haplotype effect...
  • 130
  • 519
  • 0
Probiotics as a novel approach to modulate incretins, insulin secretion and risk factors of type 2 diabetes and complications

Probiotics as a novel approach to modulate incretins, insulin secretion and risk factors of type 2 diabetes and complications

Tổng hợp

... Tucker, 20 12; Brockman et al., 20 12; Cloetens et al., 20 12; Pal and Radavelli-Bagatini, 20 12; Parnell and Reimer, 20 12; Roelofsen et al., 20 10; Robertson et al., 20 03; Pereira et al., 20 02; Weickert ... [370-631] 439 [24 6- 522 ] 4 62 [386-678] OGIS [ml/min/m2] 528 ± 92 569±94 4 82 67 Adaptation index 0.808 [0.511-0. 924 ] 0.615 [0.509-0. 924 ] 0.830 [0. 720 -0.957] Disposition index 3.09 [2. 68-5.09] 2. 76 [2. 33-3.08] ... subsequent type diabetes (Axelsen et al., 1999; Groop et al., 1996; Stumvoll et al., 20 05; Pratipanawatr et al., 20 01) Fig The current paradigm of the development of type diabetes Type diabetes (T2D)...
  • 105
  • 330
  • 0
Aspects of carbohydrate quality and their relevance for risk markers of type 2 diabetes and related health outcomes

Aspects of carbohydrate quality and their relevance for risk markers of type 2 diabetes and related health outcomes

Tổng hợp

... 2. 2.1 Type diabetes mellitus 2. 2 .2 Obesity 16 2. 2.3 Chronic low-grade Inflammation 18 2. 2.4 Hepatic insulin resistance and nonalcoholic fatty liver disease 20 ... 20 2. 2.5 Relevance in different stages of life 21 2. 3 Evidence linking carbohydrate quality to risk markers of type diabetes mellitus and related health outcomes 23 2. 3.1 ... grain 2. 1 .2 Added sugar 2. 1.3 Dietary Glycemic Index and Glycemic Load 2. 1.4 Dietary Insulin Index and Insulin Load 2. 2 Risk markers of type diabetes mellitus...
  • 203
  • 431
  • 0
Báo cáo y học:

Báo cáo y học: "Efficiency of vibration exercise for glycemic control in type 2 diabetes patients."

Y học thưởng thức

... 100 ml) 120 ± 25 126 ± 23 133 ± 57 Plasma [glucose] posttraining (mg / 100 ml) 115 ± 22 120 ± 22 122 ± 35 Significance n.s n.s n.s HbA1C At baseline the HbA1c amounted to 6,7 % ± 0 ,26 (FT), 6,8 ... diabetes Diabetes care 20 02; 25 : 1 729 – 36 Fenicchia LM, Kanaley JA, Azevedo JL, et al Influence of resistance training on glucose control in women with type diabetes Metabolism 20 04; 53: 28 4 - ... (number of subjects) Age (years) Weight (kp) Height (cm) Stretching (13) Strength (13) 63,3 ± 5,9 62, 9 ± 7,3 62, 2 ± 4,0 88,6 ± 24 ,1 86,5 ± 14,7 83,3 ± 13,4 173 ± 14 ,2 1 72 ± 6,7 177 ± 7 ,2 Vibration...
  • 5
  • 544
  • 0
Tài liệu Báo cáo khoa học: Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects Implications for a mechanism linking obesity and type 2 diabetes pdf

Tài liệu Báo cáo khoa học: Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects Implications for a mechanism linking obesity and type 2 diabetes pdf

Báo cáo khoa học

... 0.090. 02* * 0.310.04* 0.060.01** 0. 120 .04* 0 .20 0. 02* 0 .21 0.01 0.140. 02 0.460.01 ) 0.030.01 0.060.01 0.130.03 0 .24 0.01 0.090. 02* * 0.300.03* ) 0.040.01 0.150.05* 0 .24 0. 02* * 0 .26 0. 02 0.140. 02* 0.140.01 ... 0.090.01 4 .28 1.68 0 .25 0.07 0. 020 .08 ) 0.010.00 0.050.18 ) 1.100.18 0.160.01 ) 0. 620 .11 0. 620 .17 0 .25 0.44 0.170.08 0. 020 .38 ) 5.000.89 ) 0. 120 .01 FEBS Journal 27 3 (20 06) 528 8–53 02 ª 20 06 The Authors ... 0.140. 02* 0.140.01 0.140.01** 0 .22 0. 02 0 .20 0.01* 0.150.01 0 .27 0.04 0.150. 02 ) 0.030.00 0.310.04 0.140.01 0.160.04 0.160. 02* 0.160. 02 ) 0.060.01** 0 .28 0.03 0 .26 0.01** 0 .20 0.01 *P < 0.05 and **P < 0.01...
  • 15
  • 546
  • 0

Xem thêm